Open in Screener

GTX

Garrett Motion Inc

May 15 • 04:00PM ET

30.98

-0.89 -2.79 %

Consumer Cyclical • Auto Parts • Switzerland • Mid • NASD

| Held by: IWM IWN VXF DFAS SCHA DFMC VTWO SYLD FYC DFAC

Index	RUT	P/E	17.99	EPS (ttm)	1.72	Insider Own	9.30%	Shs Outstand	187.74M	Perf Week	6.83%
Market Cap	5.80B	Forward P/E	14.54	EPS next Y	2.13	Insider Trans	-2.99%	Shs Float	169.77M	Perf Month	60.68%
Enterprise Value	7.12B	PEG	0.93	EPS next Q	0.47	Inst Own	89.98%	Short Float	5.22%	Perf Quarter	45.79%
Income	343.00M	P/S	1.57	EPS this Y	15.68%	Inst Trans	6.47%	Short Ratio	3.48	Perf Half Y	80.85%
Sales	3.69B	P/B	-	EPS next Y	12.09%	ROA	14.76%	Short Interest	8.86M	Perf YTD	77.74%
Book/sh	-4.16	P/C	40.27	EPS next 5Y	15.67%	ROE	-	52W High	32.44 -4.50%	Perf Year	160.77%
Cash/sh	0.77	P/FCF	15.26	EPS past 3/5Y	26.45% 7.69%	ROIC	51.35%	52W Low	9.57 223.72%	Perf 3Y	282.94%
Dividend Est.	0.24 (0.77%)	EV/EBITDA	11.38	Sales past 3/5Y	-0.18% 3.39%	Gross Margin	24.25%	Volatility	3.86% 4.43%	Perf 5Y	408.70%
Dividend TTM	0.28 (0.90%)	EV/Sales	1.93	EPS Y/Y TTM	34.94%	Oper. Margin	14.20%	ATR (14)	1.12	Perf 10Y	-
Dividend Ex-Date	Jun 01, 2026	Quick Ratio	0.76	Sales Y/Y TTM	7.36%	Profit Margin	9.29%	RSI (14)	80.85	Recom	1.83
Dividend Gr. 3/5Y	- -	Current Ratio	0.98	EPS Q/Q	64.61%	SMA20	23.45%	Beta	0.76	Target Price	30.17
Payout	13.14%	Debt/Eq	-	Sales Q/Q	12.19%	SMA50	47.31%	Rel Volume	0.79	Prev Close	31.87
Employees	6700	LT Debt/Eq	-	Earnings	Apr 30 BMO	SMA200	79.51%	Avg Volume	2.55M	Price	30.98
IPO	Sep 17, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	32.31% 7.92%	Trades		Volume	2,022,266	Change	-2.79%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-17-25	Initiated	JP Morgan	Overweight	$23
Oct-20-25	Initiated	Deutsche Bank	Hold	$14
Sep-19-25	Initiated	Stifel	Buy	$17.50
Jul-16-25	Initiated	BNP Paribas Exane	Outperform	$14
Jun-03-21	Initiated	BWS Financial	Buy	$15

May-12-26 09:00AM	Ingersoll Rand and Garrett Motion Announce Strategic Partnership to Introduce a New Era for OilFree Industrial Innovation (Business Wire)
May-11-26 11:45AM	Garrett Motion Inc. (GTX) Hits Fresh High: Is There Still Room to Run? (Quartz)
May-01-26 08:30AM	Garrett Motion Inc. Q1 2026 Earnings Call Summary (Moby)
Apr-30-26 07:05AM	Garrett Motion: Q1 Earnings Snapshot (Associated Press) +24.99%
06:55AM	Garrett Motion Reports First Quarter 2026 Financial Results, Raises 2026 Outlook (GlobeNewswire)
02:00AM	Loading…
Apr-27-26 02:00AM	Garrett Motion's Breakthrough Oil-Free Centrifugal Compressor Enhances High-Efficiency Liquid Cooling Solutions (GlobeNewswire)
Apr-10-26 07:00AM	Garrett Motion to Hold First Quarter 2026 Financial Results Conference Call on Thursday April 30, 2026 (GlobeNewswire)
Apr-08-26 02:10AM	Garrett Motion Showcases Breakthrough Oil-Free Centrifugal Compressor Portfolio at China Refrigeration Expo 2026 (GlobeNewswire) +5.19%
Mar-25-26 07:00AM	Garrett Motion to hold Technology and Investor Day on Wednesday May 20, 2026 in New York City (GlobeNewswire)
Feb-27-26 08:56AM	Garrett Motion (GTX) Added by Harbor Mid Cap Value Fund on Strong Momentum (Insider Monkey)
Feb-24-26 07:00AM	Garrett Motion Announces Participation at the Bank of America Global Automotive Summit (GlobeNewswire) +5.13%
Feb-20-26 08:41AM	What's Going On With Garrett Motion Stock Friday? (Benzinga)
04:00AM	Garrett Motion's E-Cooling Compressor is Redefining Thermal Management Efficiency & Power for Electric Buses and Trucks in China (GlobeNewswire)
12:33AM	GTX Q4 Deep Dive: Margin Compression Overshadows New Industrial Cooling Growth Initiatives (StockStory)
Feb-19-26 04:02PM	Garrett Motion Inc (GTX) Q4 2025 Earnings Call Highlights: Strong Financial Performance and ... (GuruFocus.com) -6.39%
01:43PM	Loading…
01:43PM	GTX Shares Lower on Cautious FY26 Automotive Production Outlook (Benzinga)
12:32PM	Garrett Motion Inc. Q4 2025 Earnings Call Summary (Moby)
08:05AM	Garrett Motion (GTX) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:20AM	Garrett Motion: Q4 Earnings Snapshot (Associated Press Finance)
07:10AM	Garrett Motion (NASDAQ:GTX) Surprises With Q4 CY2025 Sales But Stock Drops (StockStory)
06:55AM	Garrett Motion Reports Strong 2025 Results and Expansion of Zero-Emission and Industrial Technology Portfolio, Issues 2026 Outlook (GlobeNewswire)
Feb-18-26 08:35AM	OPENLANE (OPLN) Q4 Earnings Miss Estimates (Zacks)
Feb-17-26 10:30AM	Garrett Gears Up to Report Q4 Earnings: What's in the Cards? (Zacks)
10:25AM	Carvana Gears Up to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-12-26 10:00AM	Earnings Preview: Garrett Motion (GTX) Q4 Earnings Expected to Decline (Zacks)
07:02AM	Garrett Motion Stock Hits 52-Week High Thursday - Here's Why (Benzinga)
04:02AM	Garrett Motion Launching First Commercial Application of its MEG Turbo Platform with Weichai Marine and Genset Engines (GlobeNewswire)
Feb-02-26 09:54AM	Latest Zero-Emission Offerings Spark Bullish Views on Garrett Motion (GTX) (Insider Monkey)
08:06AM	Garrett Motion introduces breakthrough oil-free centrifugal compressor technology for HVAC systems at AHR Expo 2026 in Las Vegas (GlobeNewswire)
07:00AM	Trane Technologies and Garrett Motion Collaborate to Advance Ultra High Efficiency Commercial HVAC Solutions (GlobeNewswire)
11:47AM	Loading…
Jan-30-26 11:47AM	Garrett Motion Stays in the Fast Lane with Scuderia Ferrari HP (GlobeNewswire)
Jan-23-26 12:10PM	Will Garrett Motion (GTX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-18-26 10:31PM	Electrical Systems Stocks Q3 Highlights: Garrett Motion (NASDAQ:GTX) (StockStory)
Jan-16-26 10:26AM	Wall Street Maintains a Positive Opinion on ?Garrett Motion Inc. (GTX) (Insider Monkey)
08:21AM	Garrett Motion to Hold Fourth Quarter 2025 Financial Results Conference Call on Thursday February 19, 2026 (GlobeNewswire)
Jan-09-26 06:04AM	J.P. Morgan Bangs the Drum on These 2 Strong Buy Stocks (TipRanks)
Jan-01-26 03:29PM	Garrett Motion (NASDAQ:GTX) Reports Bullish Q3 CY2025 (StockStory)
Dec-29-25 09:06AM	4 Auto Stocks Wall Street Analysts Are Bullish About for 2026 (Zacks)
Dec-26-25 05:14PM	Seadrill, Vestis, Mastercraft Boat, and More Stocks See Action From Activist Investors (Barrons.com)
10:05AM	Honda to Buy Ohio Battery Plant Assets From LGES for $2.9B (Zacks)
10:02AM	Tesla Under Scrutiny Due to Model 3 Door Release Concerns (Zacks)
Dec-24-25 10:47AM	4 Auto Stocks Up More Than 50% YTD & Still Worth Buying for 2026 (Zacks)
04:11AM	Best Income Stocks to Buy for Dec. 24 (Zacks)
03:49AM	Best Value Stocks to Buy for Dec.24 (Zacks)
Dec-22-25 10:26AM	Winnebago's Q1 Earnings Surpass Expectations, Revenues Rise Y/Y (Zacks)
Dec-20-25 08:00AM	Palantir, AppLovin Lead Five Stocks In Buy Zones As Market Revs Up (Investor's Business Daily)
Dec-18-25 09:40AM	Is GARRETT MOTION (GTX) Stock Undervalued Right Now? (Zacks)
04:57AM	Best Income Stocks to Buy for Dec. 18 (Zacks)
Dec-17-25 01:52PM	Analyst 'Impressed' With This Auto Tech Provider Near Buy Point (Investor's Business Daily)
09:40AM	Is Blue Bird (BLBD) Stock Outpacing Its Auto-Tires-Trucks Peers This Year? (Zacks)
Dec-15-25 09:47AM	WeRide and Uber Roll Out Robotaxis in Dubai to Grow AV Reach (Zacks)
Dec-12-25 06:50PM	National Presto, Garrett Motion, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-04-25 10:06AM	THOR Q1 Earnings Surpass Expectations, Revenues Rise Y/Y (Zacks)
Dec-03-25 08:00AM	Garrett Motion Announces $250 Million Share Repurchase Program for 2026 (GlobeNewswire)
Dec-02-25 10:27AM	BYD to Issue Software Update for 90K Hybrids to Fix Battery Defect (Zacks)
10:18AM	Tesla Registrations in November Plunge Across Key European Markets (Zacks)
09:40AM	Is GARRETT MOTION (GTX) a Great Value Stock Right Now? (Zacks)
Dec-01-25 09:40AM	Is Blue Bird (BLBD) Outperforming Other Auto-Tires-Trucks Stocks This Year? (Zacks)
09:20AM	Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus (Zacks)
09:16AM	Here's Why You Should Retain NIO Stock in Your Portfolio Now (Zacks)
Nov-28-25 08:18AM	Here's Why You Should Offload Copart Stock From Your Portfolio Now (Zacks)
Nov-26-25 10:45AM	NIO Q3 Loss Narrower Than Expected, Revenues Increase Y/Y (Zacks)
Nov-21-25 10:43AM	Copart Q1 Earnings Surpass Expectations, Revenues Increase Y/Y (Zacks)
Nov-20-25 10:17AM	Here's Why You Should Retain Advance Auto Stock in Your Portfolio Now (Zacks)
10:05AM	Here's Why You Should Retain LKQ Stock in Your Portfolio Now (Zacks)
Nov-18-25 10:35AM	Here's Why You Should Retain Toyota Stock in Your Portfolio Now (Zacks)
Nov-17-25 08:58AM	Here's Why You Should Offload Honda Stock From Your Portfolio (Zacks)
Nov-16-25 08:00AM	The 3 auto supplier stocks this portfolio mgr. is watching (Yahoo Finance Video)
Nov-14-25 06:00PM	Bitdeer, Pacira BioSciences, Garrett Motion, and More Stocks See Action From Activist Investors (Barrons.com)
09:40AM	Are Auto-Tires-Trucks Stocks Lagging GARRETT MOTION (GTX) This Year? (Zacks)
Nov-13-25 10:13AM	Honda Q2 Earnings Miss Expectations, Revenues Decline Y/Y (Zacks)
10:07AM	Toyota Q2 Earnings Miss Expectations, Revenues Rise Y/Y (Zacks)
09:28AM	Westport Q3 Earnings Surpass Expectations, Decrease Y/Y (Zacks)
Nov-12-25 09:00AM	American Axle Q3 Earnings Surpass Estimates, Decrease Y/Y (Zacks)
Nov-11-25 08:50AM	Top-Rated Low-Beta Stocks: Bet on USAC, FUTU & GTX Right Away (Zacks)
Nov-07-25 07:26PM	MapLight Therapeutics, Gold Royalty, and More Stocks See Action From Activist Investors (Barrons.com)
09:41AM	Adient Q4 Earnings Miss Expectations, Revenues Rise Y/Y (Zacks)
Nov-06-25 10:50AM	Rivian Q3 Earnings Beat Expectations, Revenues Increase Y/Y (Zacks)
Nov-05-25 05:00PM	Garrett Motion Announces Participation at Baird Global Industrial Conference (GlobeNewswire)
02:00PM	4 Low-PEG Value Stocks That Could Deliver Market-Beating Returns (Zacks)
10:52AM	Standard Motor Q3 Earnings Top Estimates, Guidance Revised (Zacks)
10:37AM	Harley Q3 Earnings Surpass Expectations, Revenues Rise Y/Y (Zacks)
Nov-04-25 09:26AM	Goodyear Q3 Earnings Beat Expectations, Revenues Decline Y/Y (Zacks)
Nov-03-25 11:56AM	Magna Q3 Earnings Surpass Expectations, Guidance Revised (Zacks)
11:52AM	Advance Auto Beats Q3 Earnings Estimates, Narrows 2025 Sales Outlook (Zacks)
Oct-31-25 10:58AM	Penske Q3 Earnings Miss Expectations, Revenues Rise Y/Y (Zacks)
Oct-30-25 11:05AM	BorgWarner Q3 Earnings Surpass Estimates, Increase Y/Y (Zacks)
10:35AM	Allison Transmission Q3 Earnings Miss Estimates, Guidance Trimmed (Zacks)
Oct-29-25 11:09AM	Asbury Q3 Earnings Surpass Estimates, Revenues Rise Y/Y (Zacks)
10:50AM	Group 1 Q3 Earnings Miss Estimates, Revenues Increase Y/Y (Zacks)
09:40AM	Is BRP (DOOO) Outperforming Other Auto-Tires-Trucks Stocks This Year? (Zacks)
Oct-27-25 12:20PM	Earnings Estimates Rising for Garrett Motion (GTX): Will It Gain? (Zacks)
07:12AM	Garrett Motion (GTX) Gets 33% Boost from Stellar Earnings (Insider Monkey)
Oct-25-25 12:45PM	Garrett Motion (GTX) Climbs to Fresh High on Impressive Earnings, Upbeat Outlook (Insider Monkey)
Oct-24-25 06:16PM	Novavax, Core Scientific, and More Stocks See Action From Activist Investors (Barrons.com) +13.80%
10:13AM	Sonic Automotive Q3 Earnings Miss Expectations, Revenues Rise Y/Y (Zacks)
10:06AM	AutoNation's Q3 Earnings Surpass Estimates, Revenues Rise Y/Y (Zacks)
10:02AM	O'Reilly Q3 Earnings Beat Expectations, 2025 FCF Guidance Trimmed (Zacks)
09:15AM	Garrett Motion Inc. (GTX) Hit a 52 Week High, Can the Run Continue? (Zacks)
08:42AM	Garrett Motion (GTX) Soars to New Record High on Higher Earnings, Outlook, Dividend (Insider Monkey)

Garrett Motion, Inc. is an automobile technology, which engages in the provision of design, manufacture, and sale of engineered turbocharger, electric motor technologies for original equipment manufacturers and distributors within the mobility and industrial space. It offers light vehicle gasoline, light vehicle diesel, and commercial vehicle turbochargers. The company was founded on March 14, 2018 and is headquartered in Rolle, Switzerland.

PresidentMr. Olivier Rabiller

Senior VP & CFOMr. Sean Ernest Deason C.M.A.

Senior VP & CTOMr. Craig Balis

Senior Vice President of Integrated Supply ChainMr. Thierry Mabru

VPMs. Joanne Lau

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NINIVAGGI DANIEL A	Director	May 15 '26	Sale	31.22	17,178	536,294	124,885	May 15 09:01 PM
Daniel A. Ninivaggi	Director	May 15 '26	Proposed Sale	31.35	17,178	538,530		May 15 04:39 PM
Rabiller Olivier	President & CEO	Feb 27 '26	Sale	20.32	144,000	2,925,950	905,546	Feb 27 09:04 PM
Rabiller Olivier	President & CEO	Feb 25 '26	Sale	20.32	143,000	2,905,488	1,192,546	Feb 27 09:04 PM
Rabiller Olivier	President & CEO	Feb 26 '26	Sale	20.29	143,000	2,901,041	1,049,546	Feb 27 09:04 PM
Deiro Daniel	SVP, CM & GM Japan/Korea	Feb 26 '26	Sale	20.29	20,000	405,710	160,994	Feb 27 09:03 PM
Deiro Daniel	SVP, CM & GM Japan/Korea	Feb 25 '26	Sale	20.31	13,000	264,088	180,994	Feb 27 09:03 PM
Steyn Julia	Director	Feb 24 '26	Sale	19.86	17,000	337,687	50,233	Feb 26 09:00 PM
Rabiller Olivier	Officer	Feb 25 '26	Proposed Sale	20.32	430,000	8,736,783		Feb 25 04:09 PM
Spenninck Fabrice	Officer	Feb 25 '26	Proposed Sale	20.31	39,000	792,254		Feb 25 04:07 PM
Deiro Daniel	Officer	Feb 25 '26	Proposed Sale	20.20	33,000	666,600		Feb 25 04:07 PM
JULIA STEYN	Director	Feb 24 '26	Proposed Sale	19.28	17,000	327,760		Feb 24 04:25 PM
Oaktree Capital Group Holdings	10% Owner	Nov 10 '25	Sale	17.00	6,300,000	107,100,000	17,094,816	Nov 13 07:52 PM
Oaktree Value Opportunities Fu	Owner	Nov 10 '25	Proposed Sale	17.55	6,300,000	110,565,000		Nov 10 05:51 PM
Oaktree Capital Group Holdings	10% Owner	Nov 03 '25	Sale	16.26	2,500,000	40,650,000	23,394,816	Nov 05 08:12 PM
Oaktree Capital Group Holdings	10% Owner	Oct 27 '25	Sale	16.25	6,000,000	97,500,000	25,894,816	Oct 29 04:01 PM
Oaktree Value Opportunities Fu	Owner	Oct 27 '25	Proposed Sale	16.99	6,000,000	101,940,000		Oct 27 08:48 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Sep 11 '25	Sale	13.28	350,566	4,654,044	20,009,945	Sep 11 05:25 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Sep 10 '25	Sale	13.23	239,612	3,169,060	20,360,511	Sep 11 05:25 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Sep 09 '25	Sale	13.25	23,225	307,734	20,600,123	Sep 11 05:25 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Aug 22 '25	Sale	13.28	500,000	6,640,800	20,623,348	Aug 26 04:52 PM
Oaktree Capital Group Holdings	10% Owner	Aug 20 '25	Sale	12.42	5,000,000	62,100,000	31,894,816	Aug 21 08:18 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Aug 19 '25	Sale	13.00	1,300,000	16,901,820	21,128,348	Aug 21 06:03 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Aug 20 '25	Sale	13.25	5,000	66,258	21,123,348	Aug 21 06:03 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Aug 18 '25	Sale	13.01	150,629	1,959,638	22,428,348	Aug 19 04:15 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Aug 15 '25	Sale	13.01	876	11,393	22,578,977	Aug 19 04:15 PM
Centerbridge Credit Partners M		Aug 13 '25	Sale	12.27	9,000,000	110,430,000	4,740,569	Aug 15 05:47 PM
Centerbridge Credit Partners M	10% Owner	Aug 06 '25	Sale	12.17	5,100,000	62,067,000	7,405,469	Aug 08 04:01 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 31 '25	Sale	13.05	90,542	1,181,220	22,580,758	Aug 04 05:14 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Aug 01 '25	Sale	13.02	705	9,176	22,580,053	Aug 04 05:14 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Aug 04 '25	Sale	13.01	200	2,602	22,579,853	Aug 04 05:14 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 28 '25	Sale	13.14	93,334	1,226,166	22,753,661	Jul 30 05:47 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 29 '25	Sale	13.05	50,000	652,605	22,703,661	Jul 30 05:47 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 30 '25	Sale	13.03	32,361	421,576	22,671,300	Jul 30 05:47 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 23 '25	Sale	11.80	58,829	694,047	22,846,995	Jul 23 06:11 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 21 '25	Sale	11.76	43	506	22,905,824	Jul 23 06:11 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 16 '25	Sale	11.63	51,718	601,491	22,931,072	Jul 18 05:58 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 17 '25	Sale	11.82	24,033	284,012	22,907,039	Jul 18 05:58 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 18 '25	Sale	11.76	1,172	13,782	22,905,867	Jul 18 05:58 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 10 '25	Sale	11.50	150,896	1,735,847	22,982,790	Jul 11 04:35 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 07 '25	Sale	11.10	300,000	3,330,990	23,133,686	Jul 09 04:49 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jul 02 '25	Sale	11.00	51,865	570,671	23,653,333	Jul 03 03:07 PM
CYRUS CAPITAL PARTNERS, L.P.	10% Owner	Jun 27 '25	Sale	10.46	1,196,526	12,514,106	23,705,198	Jul 01 04:30 PM
Oaktree Capital Group Holdings	10% Owner	May 29 '25	Sale	10.30	7,000,000	72,100,000	36,894,816	May 30 09:52 PM
Oaktree Capital Group Holdings	10% Owner	May 28 '25	Sale	11.10	188,000	2,086,800	43,894,816	May 30 09:52 PM
Centerbridge Credit Partners M	10% Owner	May 29 '25	Sale	10.30	3,000,000	30,900,000	8,906,010	May 30 06:36 PM
Oaktree Value Opportunities Fu	Owner	May 28 '25	Proposed Sale	10.96	10,000,000	109,600,000		May 28 09:24 PM

INDV Indivior Pharmaceuticals Inc daily Stock Chart

Peers: ALKS COLL JAZZ ACAD SUPN

| Held by: IJR VTI IWM VB XSMO VBK SPSM VXF IJT IWO

Index	RUT	P/E	18.62	EPS (ttm)	1.97	Insider Own	6.90%	Shs Outstand	122.00M	Perf Week	-6.94%
Market Cap	4.48B	Forward P/E	9.64	EPS next Y	3.81	Insider Trans	0.07%	Shs Float	116.16M	Perf Month	16.66%
Enterprise Value	4.82B	PEG	0.50	EPS next Q	0.83	Inst Own	109.21%	Short Float	11.04%	Perf Quarter	6.30%
Income	251.00M	P/S	3.47	EPS this Y	39.71%	Inst Trans	6.63%	Short Ratio	4.81	Perf Half Y	22.13%
Sales	1.29B	P/B	-	EPS next Y	9.20%	ROA	19.52%	Short Interest	12.82M	Perf YTD	2.45%
Book/sh	-1.18	P/C	25.61	EPS next 5Y	19.12%	ROE	-	52W High	41.00 -10.34%	Perf Year	232.07%
Cash/sh	1.44	P/FCF	-	EPS past 3/5Y	- -	ROIC	70.51%	52W Low	10.63 245.81%	Perf 3Y	94.29%
Dividend Est.	-	EV/EBITDA	10.58	Sales past 3/5Y	11.20% 13.88%	Gross Margin	83.11%	Volatility	2.54% 3.80%	Perf 5Y	256.89%
Dividend TTM	-	EV/Sales	3.73	EPS Y/Y TTM	998.17%	Oper. Margin	33.93%	ATR (14)	1.41	Perf 10Y	231.17%
Dividend Ex-Date	-	Quick Ratio	0.66	Sales Y/Y TTM	10.34%	Profit Margin	19.44%	RSI (14)	54.20	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.86	EPS Q/Q	83.48%	SMA20	0.70%	Beta	1.19	Target Price	49.71
Payout	0.00%	Debt/Eq	-	Sales Q/Q	19.17%	SMA50	10.69%	Rel Volume	0.68	Prev Close	37.83
Employees	838	LT Debt/Eq	-	Earnings	Apr 30 BMO	SMA200	20.90%	Avg Volume	2.67M	Price	36.76
IPO	Dec 29, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	45.45% 16.19%	Trades		Volume	1,816,386	Change	-2.83%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Initiated	H.C. Wainwright	Buy	$27
Jul-22-25	Resumed	Jefferies	Buy	$20
Jan-28-25	Initiated	Rodman & Renshaw	Buy	$16
Jul-23-24	Initiated	Piper Sandler	Overweight	$22
Apr-03-24	Initiated	Craig Hallum	Buy	$37
Jul-13-23	Initiated	Northland Capital	Outperform	$35

May-14-26 07:00AM	Indivior to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-26 01:38PM	Medical Stock In Buy Zone After Breakout By Opioid-Addiction Treatment Maker (Investor's Business Daily)
May-04-26 07:00AM	Indivior Announces $175 Million Accelerated Share Repurchase (GlobeNewswire)
Apr-30-26 07:00AM	Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance (GlobeNewswire) +7.70%
Apr-24-26 11:00AM	Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder (GlobeNewswire)
02:30PM	Loading…
Apr-16-26 02:30PM	Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse (GlobeNewswire)
Apr-09-26 07:00AM	Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th (GlobeNewswire)
Mar-31-26 09:00AM	New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities (GlobeNewswire) +5.91%
Mar-17-26 12:02PM	National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder (GlobeNewswire)
Mar-12-26 08:30PM	Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering (GlobeNewswire) -6.00%
07:00AM	Indivior Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)
Mar-11-26 09:00AM	New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder (GlobeNewswire)
Mar-09-26 12:35PM	Implied Volatility Surging for Indivior Pharmaceuticals Stock Options (Zacks)
Feb-26-26 08:05PM	Indivior PLC Q4 2025 Earnings Call Summary (Moby)
09:55AM	Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates (Zacks)
09:16AM	Loading…
09:16AM	Indivior Q4 Earnings Call Highlights (MarketBeat)
07:00AM	Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results (GlobeNewswire)
Feb-24-26 07:00AM	Indivior to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-19-26 09:45AM	Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-28-26 07:00AM	Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26?? (GlobeNewswire)
Jan-26-26 07:00AM	Indivior Announces Completion of Redomiciliation to the United States (GlobeNewswire)
Jan-21-26 07:17AM	Strength Seen in Ardelyx (ARDX): Can Its 15.0% Jump Turn into More Strength? (Zacks)
04:54AM	'Follow The Money,' Not The Tariff Noise, Says Expert, Spotlights This New S&P Data Center Cooling Stock Among Top Picks (Benzinga)
Jan-13-26 09:19AM	Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes (Zacks)
Jan-12-26 10:14AM	PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates (Zacks)
10:08AM	TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug (Zacks)
08:43AM	Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus (Zacks)
Jan-10-26 02:57PM	Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance (Insider Monkey)
Jan-09-26 11:46AM	AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations (Zacks)
Jan-08-26 11:09AM	GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug (Zacks)
08:57AM	Loading…
08:57AM	4 Stocks Trading Near 52-Week High With Room to Rise Further (Zacks)
07:00AM	Indivior Provides Full-Year 2026 Financial Guidance and Business Update (GlobeNewswire)
Jan-07-26 11:45AM	FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug (Zacks)
09:53AM	OTLK Stock Crashes 67% in a Week: Here's What You Need to Know (Zacks)
Jan-06-26 11:53AM	ALT Stock Up 17% After Pemvidutide Gets FDA Breakthrough Tag for MASH (Zacks)
Dec-30-25 10:32AM	Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher (Barchart)
Dec-22-25 07:00AM	Indivior Announces Inclusion in the S&P SmallCap 600 Index (PR Newswire)
06:00AM	2026 outlook: Small-cap biotechs may fill gaps on drug pipelines (Yahoo Finance Video)
Dec-17-25 11:30AM	New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations (PR Newswire)
Dec-05-25 05:49PM	CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Nov-20-25 04:01PM	Indivior Concludes Legacy U.S. Department of Justice Matter (PR Newswire)
Nov-19-25 09:21AM	Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference (PR Newswire)
Nov-07-25 08:37AM	4 Must-Buy Efficient Stocks to Enrich Your Portfolio in 2025 (Zacks)
Nov-06-25 03:25PM	3 Top Ranked Stocks that are the Best of the Best (Zacks)
Nov-03-25 08:00AM	Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine (PR Newswire) +6.23%
Oct-31-25 10:03AM	Indivior (INDV) Jumps to New High on Earnings Blowout, Optimistic Outlook (Insider Monkey)
Oct-30-25 04:22PM	Indivior PLC (INDV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +15.41%
02:18PM	Here's Why Indivior Stock Soared 15% Today (Motley Fool)
08:30AM	Indivior PLC (INDV) Beats Q3 Earnings and Revenue Estimates (Zacks)
07:00AM	Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance (PR Newswire)
Oct-29-25 09:40AM	Indivior PLC (INDV) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-28-25 10:00AM	Indivior to Participate in the Stifel 2025 Healthcare Conference (PR Newswire)
Oct-23-25 09:21AM	Indivior PLC (INDV) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-16-25 04:04PM	Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th (PR Newswire)
Oct-15-25 08:00AM	Clinical Evidence Supports Rapid SUBLOCADE Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment (PR Newswire)
Oct-01-25 08:00AM	Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation (PR Newswire)
Sep-30-25 12:47PM	Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M (Insider Monkey)
Sep-10-25 12:00PM	What Makes Indivior PLC (INDV) a Strong Momentum Stock: Buy Now? (Zacks)
Sep-09-25 11:57AM	Top 100 Stocks to Buy: Indivior Advances Into Top 50 on Momentum (Barchart)
Aug-20-25 12:00PM	Indivior to Participate in Upcoming Investor Events (PR Newswire)
Aug-06-25 09:36AM	Snap downgraded, Leidos upgraded: Wall Street's top analyst calls (The Fly)
Aug-05-25 12:00PM	All You Need to Know About Indivior (INDV) Rating Upgrade to Strong Buy (Zacks)
10:00AM	Best Momentum Stock to Buy for August 5th (Zacks)
06:16AM	New Strong Buy Stocks for August 5th (Zacks)
Aug-03-25 12:32PM	Indivior Plc (INDV) Jumps 22.8% on Impressive Earnings, Outlook (Insider Monkey)
Aug-01-25 01:23PM	Indivior (INDV) Extends Jump on 3rd Day with 16% Gain (Insider Monkey)
Jul-31-25 08:15AM	Indivior PLC (INDV) Tops Q2 Earnings and Revenue Estimates (Zacks) +16.09%
07:00AM	Indivior Reports Second Quarter 2025 Financial Results and Raises FY 2025 Financial Guidance (PR Newswire)
Jul-30-25 09:43AM	Indivior PLC (INDV) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-28-25 10:06AM	Indivior PLC (INDV) Reinvents Leadership, Moves Listing to Nasdaq (Insider Monkey)
10:00AM	BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-25-25 02:00AM	Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained (PR Newswire)
Jul-24-25 10:00AM	Indivior PLC (INDV) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-23-25 08:00AM	Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid Use Disorder (PR Newswire)
Jul-17-25 09:00AM	Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st (PR Newswire)
Jul-08-25 08:00AM	Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs (PR Newswire)
Jul-01-25 07:05AM	Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Jun-30-25 07:00AM	Indivior Announces Inclusion in the U.S. Russell 2000 and 3000 Indexes (PR Newswire) +5.66%
Jun-27-25 05:45PM	IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
Jun-24-25 04:12PM	Indivior Appoints Tony Kingsley to the Board of Directors (PR Newswire)
02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
10:40AM	Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength? (Zacks)
07:56AM	RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Jun-20-25 03:01AM	Addex Therapeutics Ltd (ADXN) Q1 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Jun-19-25 09:00AM	Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users (PR Newswire)
Jun-05-25 05:08AM	Wise Plans to Shift Main Listing to US in Latest London Loss (Bloomberg)
Jun-02-25 05:24AM	FTSE pharma giant joins London stock market exodus (The Telegraph)
02:00AM	Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained (PR Newswire)
May-27-25 08:30AM	Indivior Announces Patrick Barry as Chief Commercial Officer (PR Newswire) +5.02%
May-13-25 10:00AM	Indivior to Participate in Upcoming Investor Events (PR Newswire)
May-01-25 10:27AM	New Study Highlights Monthly SUBLOCADE as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy (PR Newswire)
Apr-28-25 12:12PM	Indivior: Trying To Break Addiction (Seeking Alpha)
Apr-24-25 10:45AM	Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript (Seeking Alpha) +13.86%
07:05AM	Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates (Zacks)
03:58AM	Indivior Q1 Net Income Declines; Net Revenue Down 6% (RTT News)
02:00AM	Indivior Announces Q1 2025 Financial Results (PR Newswire)
Apr-02-25 04:12AM	Indivior: A Complicated Story Of Both Declining Revenue And Strong Financials (Seeking Alpha)
Mar-31-25 07:51PM	Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks' Oaktree Capital Management? (Insider Monkey)
Mar-27-25 05:35PM	Plus Therapeutics (PSTV) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-04-25 08:40AM	Indivior Announces Further Changes to Board of Directors (PR Newswire) +5.76%

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

CEO & DirectorMr. Joseph J. Ciaffoni

Chief Commercial OfficerMr. Patrick a. Barry

Chief Integrity & Compliance OfficerMr. Kevin L. Espinoza

Chief Human Resources OfficerMs. Angela Colon-Mahoney M.S.

Executive Vice President of Corporate AffairsMs. Vanessa Procter

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ryan Barbara	Director	Mar 13 '26	Buy	31.09	8	249	5,724	Mar 13 04:25 PM
Kingsley Stuart A	Director	Mar 06 '26	Buy	31.86	940	29,953	5,582	Mar 11 09:54 AM
Ryan Barbara	Director	Mar 09 '26	Buy	32.56	31	1,009	5,716	Mar 11 08:12 AM
Ryan Barbara	Director	Jan 05 '26	Buy	35.39	775	27,429	1,963	Jan 07 01:51 PM
Humphreys Keith	Director	Jan 05 '26	Buy	35.39	775	27,429	5,802	Jan 07 01:50 PM
NINIVAGGI DANIEL A	Director	Jan 05 '26	Buy	35.39	775	27,429	16,923	Jan 07 01:49 PM
Stejbach Mark	Director	Jan 05 '26	Buy	35.39	775	27,429	16,847	Jan 07 01:48 PM
Wheadon David E.	Director	Jan 05 '26	Buy	35.39	1,771	62,680	14,395	Jan 07 01:47 PM
Cetani Cynthia C	Officer	Nov 07 '25	Proposed Sale	30.65	121,737	3,731,762		Nov 07 04:05 PM
Crossley Mark	Affiliate	Sep 08 '25	Proposed Sale	24.75	26,463	655,000		Sep 08 04:26 PM
Mark Crossley	affiliate	Sep 08 '25	Proposed Sale	24.97	183,938	4,593,151		Sep 08 02:24 PM
Mark Crossley	affiliate	Sep 04 '25	Proposed Sale	24.80	30,000	744,010		Sep 04 12:59 PM
Mark Crossley	affiliate	Aug 28 '25	Proposed Sale	24.43	52,320	1,278,178		Aug 28 12:15 PM

GTX

Garrett Motion Inc

INDV

Indivior Pharmaceuticals Inc

Upgrade your Finviz experience